Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?

• Váldodahkkit: Andre Bredthauer (Dahkki), Manuel Kopfmueller (Dahkki), Michael Gruber (Dahkki), Sophie-Marie Pfaehler (Dahkki), Karla Lehle (Dahkki), Walter Petermichl (Dahkki), Timo Seyfried (Dahkki), Diane Bitzinger (Dahkki), Andreas Redel (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Hindawi-Wiley, 2020-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Introduction. Anticoagulants such as argatroban and heparins (low-molecular-weight and unfractionated) play an immense role in preventing thromboembolic complications in clinical practice. Nevertheless, they can also have a negative effect on the immune system. This study is aimed at investigating t...